Schizophrenia Research
Volume 84, Issue 2 , Pages 228-235 , June 2006

Meta-analysis of association between ApoE ε4 allele and schizophrenia

  • Ming-Qing Xu

      Affiliations

    • Bio-X Life Science Research Centre, Shanghai Jiao Tong University, Shanghai, China
    • Institute for Nutritional Sciences, Shanghai Institute of Biological Sciences, Chinese Academy of Sciences, Shanghai, China
    • ,
  • David St Clair

      Affiliations

    • Department of Mental Health, University of Aberdeen, Medical School, Foresterhill, Aberdeen AB25 2ZD, UK
    • ,
  • Lin He

      Affiliations

    • Bio-X Life Science Research Centre, Shanghai Jiao Tong University, Shanghai, China
    • Institute for Nutritional Sciences, Shanghai Institute of Biological Sciences, Chinese Academy of Sciences, Shanghai, China
    • Corresponding Author InformationCorresponding author. Shanghai Jiao Tong University, Bio-X Centre, P.O. Box 501, Hao Ran Building, 1954 Hua Shan Road, Shanghai 200030, China.

Received 4 October 2005 ,Revised 4 February 2006 ,Accepted 15 February 2006.

References 

  1. Arnold SE, Joo E, Martinoli MG, Roy N, Trojanowski JQ, Gur RE. Apolipoprotein E genotype in schizophrenia, frequency, age at onset, and neuropathological features. NeuroReport. 1997;8:1523–1526
  2. Benjamin R, Leake A, Edwardson JA, McKeith IG, Ince PG, Perry RH. Apolipoprotein E genes in Lewy body and Parkinson's disease. Lancet. 1994;343:1565
  3. Borecki IB, Suarez BK. Linkage and association, basic concepts. Adv. Genet. 2001;42:45–66
  4. Chen J, Hong CJ, Chiu HJ, Lin CY, Bai YM, Song HL. Apolipoprotein E genotype and schizophrenia. Biol. Psychiatry. 1999;39:141–143
  5. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261:921–923
  6. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat. Genet. 1994;7:180–184
  7. Das HK, McPherson J, Brun GAP, Karathanasis SK, Breslow JL. Isolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E gene. J. Biol. Chem. 1985;260:6240–6247
  8. Dean B, Laws SM, Hone E, Taddei K, Scarr E, Thomas EA. Increased levels of apolipoprotein E in the frontal cortex of subjects with schizophrenia. Biol. Psychiatry. 2003;54:616–622
  9. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control. Clin. Trials. 1986;7:177–188
  10. Digney A, Keriakous D, Scarr E, Thomas E, Dean B. Differential changes in apolipoprotein E in schizophrenia and bipolar I disorder. Biol. Psychiatry. 2005;7:711–715
  11. Durany N, Riederer P, Cruz-Sanchez FF. Apolipoprotein E genotype in Spanish schizophrenic patients. Psychiatr. Genet. 2000;10:73–77
  12. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br. Med. J. 1997;315:629–634
  13. Fan, J.B., Sklar, P., 2005. Meta-analysis reveals association between serotonin transporter gene STin2 VNTR polymorphism and schizophrenia. Mol. Psychiatry, 10, 928–38, 891.
  14. Faraone SV, Doyle AE, Mick E, Biederman J. Meta-analysis of the association between the 7-repeat allele of the dopamine D4 receptor gene and attention deficit. Am. J. Psychiatry. 2001;158:1052–1057
  15. Fernandez T, Yan WL, Hamburger S, Rapoport JL, Saunders AM, Schapiro M. Apolipoprotein E alleles in childhood-onset schizophrenia. Am. J. Med. Genet. (Neuropsychiatr. Genet.). 1999;88:211–213
  16. Frisoni GB, Calabresi L, Geroldi C, Bianchetti A, D'Acquarica AL, Govoni S. Apolipoprotein E epsilon 4 allele in Alzheimer's disease and vascular dementia. Dementia. 1994;5:240–242
  17. Glatt SJ, Faraone SV, Tsuang MT. Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia, meta-analysis of case–control and family-based studies. Am. J. Psychiatry. 2003;160:469–476
  18. Gottesman II. Schizophrenia Genesis: The Origins of Madness. New York: W H Freeman and Co; 1999;
  19. Harrington CR, Roth M, Xuereb JH, McKenna PJ, Wischik CM. Apolipoprotein E type epsilon 4 allele frequency is increased in patients with schizophrenia. Neurosci. Lett. 1995;202:101–104
  20. Harrison PJ, Weinberger DR. Schizophrenia genes, gene expression, and neuropathology, on the matter of their convergence. Mol. Psychiatry. 2005;10:40–68
  21. Igata-Yi R, Igata T, Ishizuka K, Kimura T, Sakamoto S, Katsuragi S. Apolipoprotein E genotype and psychosis. Biol. Psychiatry. 1997;41:906–908
  22. Jonsson E, Lannfelt L, Engvall B, Sedvall G. Lack of association between schizophrenia and the apolipoprotein E epsilon 4 allele. Eur. Arch. Psychiatry Clin. Neurosci. 1996;246:182–184
  23. Joober R, Rouleau G, Fon E, Lal S, Palmour R, Bloom D. Apolipoprotein E genotype in schizophrenia. Am. J. Med. Genet. (Neuropsychiatr. Genet.). 1996;67:235
  24. Kampman O, Anttila S, Illi A, Mattila KM, Rontu R, Leinonen E. Apolipoprotein E polymorphism is associated with age of onset in schizophrenia. J. Hum. Genet. 2004;49:355–359
  25. Kimura T, Yokota S, Igata-Yi R, Shono M, Takamatsu J, Miyakawa T. Apolipoprotein E epsilon2 allele and early onset schizophrenia. Neurosci. Lett. 1997;231:53–55
  26. Kimura T, Yokota S, Shono M, Igata-Yi R, Takamatsu J, Miyakawa T. Apolipoprotein E ε4 and schizophrenia. NeuroReport. 1997;8:17
  27. Kimura T, Shono M, Yokota S, Ishizuka K, Watanabe M, Takamatsu J. Apolipoprotein E ε4 and tardive dyskinesia in a Japanese population. J. Psychiatr. Res. 2000;34:329–332
  28. Kimura T, Shono M, Yokota S, Igata-Yi R, Takamatsu J, Miyakawa T. Apolipoprotein E ε3 allele is not a risk factor of schizophrenia: a study of 314 Japanese patients. Neuropsychobiology. 2000;42:66–68
  29. Lan TH, Hong CJ, Chen JY, Sim CB. Apolipoprotein E-epsilon 4 frequency in patients with schizophrenia. Biol. Psychiatry. 1997;42:225–227
  30. Laws SM, Taddei K, Martins G, Paton A, Fisher C, Clarnette R. The –491AA polymorphism in the APOE gene is associated with increased plasma ApoE levels in Alzheimer's disease. NeuroReport. 1999;10:879–882
  31. Laws SM, Hone E, Taddei K, Harper C, Dean B, McClean C. Variation at the APOE –491 promoter locus is associated with altered brain levels of apolipoprotein E. Mol. Psychiatry. 2002;7:886–890
  32. Lee MK, Park AJ, Nam BY, Min KJ, Kee BS, Park DB. Apolipoprotein E genotype in Korean schizophrenic patients. J. Korean Med. Sci. 2001;16:781–783
  33. Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I. Genome scan meta-analysis of schizophrenia and bipolar disorder: Part II. Schizophrenia. Am. J. Hum. Genet. 2003;1:34–48
  34. Liu WQ, Breen G, Zhang JG, Li S, Gu N, Feng GY, et al. Association of APOE gene with schizophrenia in Chinese, a possible risk factor in times of malnutrition. Schizophr. Res. 2003;62:225–230
  35. Lu Z. An analysis of association between dopamine D4 receptor gene and apolipoprotein E gene and schizophrenia. Chin. J. Psychiatry. 2003;36:17–20
  36. Mahadik SP, Mukherjee S. Free radical pathology and antioxidant defense in schizophrenia. Schizophr. Res. 1996;19:1–17
  37. Mahley RW, Rall SC. Apolipoprotein E, far more than a lipid transport protein. Annu. Rev. Genomics Hum. Genet. 2000;507–537
  38. Martorell L, Virgos C, Valero J, Coll G, Figuera L, Joven J. Schizophrenic women with the APOE epsilon 4 allele have a worse prognosis than those without it. Mol. Psychiatry. 2001;6:307–310
  39. Middleton FA, Pato CN, Gentile KL, McGann L, Brown AM, Trauzzi M, et al. Gene expression analysis of peripheral blood leukocytes from discordant sib-pairs with schizophrenia and bipolar disorder reveals points of convergence between genetic and functional genomic approaches. Am. J. Med. Genet. (Neuropsychiatr. Genet.). 2005;1:12–25
  40. Pickar D, Malhotra AK, Rooney W, Breier A, Goldman D. Apolipoprotein E epsilon 4 and clinical phenotype in schizophrenia. Lancet. 1997;350:930–931
  41. Plassman BL, Welsh-Bohmer KA, Bigler ED, Johnson SC, Anderson CV, Helms MJ. Apolipoprotein E ε4 allele and hippocampal volume in twins with normal cognition. Neurology. 1997;48:985–989
  42. Ravelli GP, Stein ZA, Susser MW. Obesity in young men after famine exposure in utero and early infancy. N. Engl. J. Med. 1976;7:349–353
  43. Saiz PA, Morales B, G-Portilla MP, Alvarez V, Coto E, Fernandez JM. Apolipoprotein E genotype and schizophrenia, further negative evidence. Acta Psychiatr. Scand. 2002;105:71–75
  44. Saunders AM, Schmader K, Breitner JC, Benson MD, Brown WT, Goldfarb L. Apolipoprotein E ε4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet. 1993;342:710–711
  45. Schurhoff F, Krebs MO, Szake A, Loze JY, Goldberger C, Quignon V. Apolipoprotein E in schizophrenia, a French association study and meta-analysis. Am. J. Med. Genet. (Neuropsychiatr. Genet.). 2003;119:18–23
  46. Soininen HS, Riekkinen PJ. Apolipoprotein E, memory and Alzheimer's disease. Trends Neurosci. 1996;6:224–228
  47. Song Y, Stampfer MJ, Liu SM. Meta-analysis, apolipoprotein E genotypes and risk for coronary heart disease. Ann. Intern. Med. 2004;2:137–147
  48. Sorbi S, Nacmias B, Tedde A, Latorraca S, Forleo P, Guarnieri BM. No implication of apolipoprotein E polymorphism in Italian schizophrenic patients. Neurosci. Lett. 1998;244:118–120
  49. St Clair D, Xu MQ, Wang P, Yu YQ, Fang YR, Zhang F. Rates of adult schizophrenia following prenatal exposure to the Chinese famine of 1959–1961. JAMA. 2005;5:557–562
  50. Thibaut F, Coron B, Hannequin D, Segard L, Martin C, Dollfus S. No association of apolipoprotein E epsilon 4 with schizophrenia even in cognitively impaired patients. Schizophr. Res. 1998;30:149–153
  51. Thibaut F, Van der Elst A, Campion D, Martin C, Coron B, Dollfus S. Apolipoprotein E-ε4 frequency in deficit schizophrenia. Eur. Psychiatr. 1999;14:148–151
  52. Town T, Fallin D, Crawford F, Walsh S, Solomon R, Mullan M. Lack of association between the apolipoprotein E ε4 allele (ApoE ε4) and chronic schizophrenia. Am. J. Med. Genet. (Neuropsychiatr. Genet.). 1997;74:451–452
  53. Woolf B. On estimating the relation between blood group and disease. Ann. Eugen. 1955;19:251–253
  54. Zhang LS. A study on the association between schizophrenia and APO E gene. In: Si Chuan Jing Shen Wei Sheng. vol. 11:1998;p. 233–235
  55. Zhu S, Nothen MM, Uhlhaas S, Rietschel M, Korner J, Lanczik M. Apolipoprotein E genotype distribution in schizophrenia. Psychiatr. Genet. 1996;6:75–79

PII: S0920-9964(06)00082-X

doi: 10.1016/j.schres.2006.02.015

Schizophrenia Research
Volume 84, Issue 2 , Pages 228-235 , June 2006

Article Tools